Publication:
Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly".

dc.contributor.authorGomez-Peralta, F
dc.contributor.authorCarrasco-Sanchez, F J
dc.contributor.authorPerez, A
dc.contributor.authorEscalada, J
dc.contributor.authorAlvarez-Guisasola, F
dc.contributor.authorMiranda-Fernandez-Santos, C
dc.contributor.authorMediavilla-Bravo, J J
dc.contributor.authorGomez-Huelgas, Ricardo
dc.date.accessioned2023-05-03T15:16:00Z
dc.date.available2023-05-03T15:16:00Z
dc.date.issued2022-10-01
dc.description.abstractThe population with type 2 DM (DM2) is highly heterogeneous, representing an important challenge for healthcare professionals. The therapeutic choice should be individualized, considering the functional status, frailty, the occurrence of comorbidities, and the preferences of patients and their caregivers. New evidence on the cardiovascular and renal protection of specific therapeutic groups and on the usefulness of new technologies for DM2 management, among other aspects, warrant an update of the consensus document on the DM2 in the elderly that was published in 2018.
dc.description.versionSi
dc.identifier.citationGómez-Peralta F, Carrasco-Sánchez FJ, Pérez A, Escalada J, Álvarez-Guisasola F, Miranda-Fernández-Santos C, et al. Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly". Rev Clin Esp (Barc). 2022 Oct;222(8):496-499
dc.identifier.doi10.1016/j.rceng.2022.03.005
dc.identifier.essn2254-8874
dc.identifier.pmid35753941
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.rceng.2022.03.005
dc.identifier.urihttp://hdl.handle.net/10668/22489
dc.issue.number8
dc.journal.titleRevista clinica espanola
dc.journal.titleabbreviationRev Clin Esp (Barc)
dc.language.isoen
dc.organizationHospital Universitario Juan Ramón Jiménez
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number496-499
dc.provenanceRealizada la curación de contenido 01/04/2025
dc.publisherElsevier
dc.pubmedtypePractice Guideline
dc.relation.publisherversionhttps://linkinghub.elsevier.com/retrieve/pii/S2254-8874(22)00046-7
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAntidiabetic treatment
dc.subjectDiabetes mellitus tipo 2
dc.subjectEdad avanzada
dc.subjectElderly
dc.subjectFragilidad
dc.subjectFrailty
dc.subjectTechnology applied to diabetes
dc.subjectTecnología aplicada a la diabetes
dc.subjectTratamiento antidiabético
dc.subjectType 2 diabetes mellitus
dc.subject.decsEstado Funcional
dc.subject.decsCuidadores
dc.subject.decsFragilidad
dc.subject.decsFactores Protectores
dc.subject.decsAtención a la Salud
dc.subject.meshAged
dc.subject.meshComorbidity
dc.subject.meshConsensus
dc.subject.meshDiabetes Mellitus
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshFrail Elderly
dc.subject.meshFrailty
dc.subject.meshHumans
dc.titleExecutive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly".
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number222
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Gomez-Peralta_Executive.pdf
Size:
956.99 KB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Gomez-Peralta_Executive_MaterialSuplementario.pdf
Size:
1.39 MB
Format:
Adobe Portable Document Format